Arkolith/Insider Trading/ARWR/Form 4

Perry Michael S

DirectorARROWHEAD PHARMACEUTICALS, INC. (ARWR) · full profile →Form 4 · filed Dec 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$992K
Net Open-Market Flow
-$992K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2025Sell(S)16K$61.03$992K115K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001250379-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML